Europe PMC requires Javascript to function effectively.

Either your web browser doesn't support Javascript or it is currently turned off. In the latter case, please turn on Javascript support in your web browser and reload this page.

| Create an account https://orcid.org

Search life-sciences literature (45,104,206 articles, preprints and more)

Search results

1-25 of 42 results

Sort by:

Relevance ^{Relevance: This is determined based on a ranking of criteria including term frequency, rarity of term, recency of article, whether there is a Title or Author field match, etc.}

Times cited

Date

1 2

Familial CCM Genes Might Not Be Main Drivers for Pathogenesis of Sporadic CCMs-Genetic Similarity between Cancers and Vascular Malformations.
Zhang J, Croft J, Le A
J Pers Med, 13(4):673, 17 Apr 2023
Cited by: 6 articles | PMID: 37109059 | PMCID: PMC10143507
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
2,5-Hexanedione Affects Ovarian Granulosa Cells in Swine by Regulating the CDKN1A Gene: A Transcriptome Analysis.
Chen Y, Kong C, Yang M, Liu Y, Han Z, Xu L, Zheng X, Ding Y, Yin Z, Zhang X
Vet Sci, 10(3):201, 07 Mar 2023
Cited by: 0 articles | PMID: 36977240 | PMCID: PMC10058995
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Identification of immuno-infiltrating MAP1A as a prognosis-related biomarker for bladder cancer and its ceRNA network construction.
Lyu X, Qiang Y, Zhang B, Xu W, Cui Y, Ma L
Front Oncol, 12:1016542, 02 Nov 2022
Cited by: 3 articles | PMID: 36408130 | PMCID: PMC9667867
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
NF2 Alteration/22q Loss Is Associated with Recurrence in WHO Grade 1 Sphenoid Wing Meningiomas.
Sakai Y, Miyawaki S, Teranishi Y, Okano A, Ohara K, Hongo H, Ishigami D, Shimada D, Mitsui J, Nakatomi H, Saito N
Cancers (Basel), 14(13):3183, 29 Jun 2022
Cited by: 0 articles | PMID: 35804955 | PMCID: PMC9265038
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Associations of Genetic Polymorphisms of mTOR rs2295080 T/G and rs1883965 G/A with Susceptibility of Urinary System Cancers.
Min Z, Mi Y, Lv Z, Sun Y, Tang B, Wu H, Zhang Z, Pan H, Zhang Y, Lu C, Zuo L, Zhang L
Dis Markers, 2022:1720851, 17 Jan 2022
Cited by: 3 articles | PMID: 35082928 | PMCID: PMC8786550
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Correlation of the AKT/mTOR signaling pathway with the clinicopathological features and prognosis of nasopharyngeal carcinoma.
Wang Y, Sun J, Yao N
Eur J Histochem, 65(4), 16 Nov 2021
Cited by: 8 articles | PMID: 34783234 | PMCID: PMC8611413
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Prognostic Role of the Activated p-AKT Molecule in Various Hematologic Malignancies and Solid Tumors: A Meta-Analysis.
Yao Z, Gao G, Yang J, Long Y, Wang Z, Hu W, Liu Y
Front Oncol, 10:588200, 10 Dec 2020
Cited by: 7 articles | PMID: 33363017 | PMCID: PMC7758503
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Cytokine-Mediated Dysregulation of Signaling Pathways in the Pathogenesis of Multiple Myeloma.
Akhtar S, Ali TA, Faiyaz A, Khan OS, Raza SS, Kulinski M, Omri HE, Bhat AA, Bhat AA, Uddin S
Int J Mol Sci, 21(14):E5002, 15 Jul 2020
Cited by: 17 articles | PMID: 32679860 | PMCID: PMC7403981
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The function and mechanism of circular RNAs in gastrointestinal tumours.
Nie H, Wang Y, Liao Z, Zhou J, Ou C
Cell Prolif, 53(7):e12815, 08 Jun 2020
Cited by: 40 articles | PMID: 32515024 | PMCID: PMC7377939
Add to export list Review
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Mutations in gliclazide-associated genes may predict poor bladder cancer prognosis.
Wen W, Gong J, Wu P, Zhao M, Wang M, Chen H, Sun J
FEBS Open Bio, 9(3):457-467, 06 Feb 2019
Cited by: 4 articles | PMID: 30868054 | PMCID: PMC6396154
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
The Esophageal Cancer and the PI3K/AKT/mTOR Signaling Regulatory microRNAs: a Novel Marker for Prognosis, and a Possible Target for Immunotherapy.
Javadinia SA, Shahidsales S, Fanipakdel A, Mostafapour A, Joudi-Mashhad M, Ferns GA, Avan A
Curr Pharm Des, 24(39):4646-4651, 01 Jan 2018
Cited by: 28 articles | PMID: 30636576
Add to export list Review
Analysis of the PI3K-AKT-mTOR pathway in penile cancer: evaluation of a therapeutically targetable pathway.
Adimonye A, Stankiewicz E, Kudahetti S, Trevisan G, Tinwell B, Corbishley C, Lu YJ, Watkin N, Berney D
Oncotarget, 9(22):16074-16086, 23 Mar 2018
Cited by: 9 articles | PMID: 29662627 | PMCID: PMC5882318
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Association between single nucleotide polymorphisms in the PI3K/AKT/mTOR pathway and bladder cancer risk in a sample of Iranian population.
Bizhani F, Hashemi M, Danesh H, Nouralizadeh A, Narouie B, Bahari G, Ghavami S
EXCLI J, 17:3-13, 02 Jan 2018
Cited by: 9 articles | PMID: 29383014 | PMCID: PMC5780628
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Inhibition of PI3K/AKt/mTOR signaling pathway protects against d-galactosamine/lipopolysaccharide-induced acute liver failure by chaperone-mediated autophagy in rats.
Li Y, Lu L, Luo N, Wang YQ, Gao HM
Biomed Pharmacother, 92:544-553, 01 Aug 2017
Cited by: 26 articles | PMID: 28577493
Add to export list
Immunohistochemical Investigation of HER/AKT/mTOR Pathway and Cellular Adhesion Molecules in Urothelial Carcinomas.
Koletsas N, Koletsa T, Choidas S, Anagnostopoulos K, Touloupidis S, Zaramboukas T, Raptou G, Papadopoulos N, Lambropoulou M
Patholog Res Int, 2017:6794150, 22 Jan 2017
Cited by: 4 articles | PMID: 28210516 | PMCID: PMC5292159
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
AMPKα Is Suppressed in Bladder Cancer through Macrophage-Mediated Mechanisms.
Kopsiaftis S, Hegde P, Taylor JA, Claffey KP
Transl Oncol, 9(6):606-616, 01 Dec 2016
Cited by: 9 articles | PMID: 27916296 | PMCID: PMC5143351
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Mutation of genes of the PI3K/AKT pathway in breast cancer supports their potential importance as biomarker for breast cancer aggressiveness.
Tserga A, Chatziandreou I, Michalopoulos NV, Patsouris E, Saetta AA
Virchows Arch, 469(1):35-43, 08 Apr 2016
Cited by: 22 articles | PMID: 27059323
Add to export list
The Prognostic Influence of BRAF Mutation and other Molecular, Clinical and Laboratory Parameters in Stage IV Colorectal Cancer.
Karadima ML, Saetta AA, Chatziandreou I, Lazaris AC, Patsouris E, Tsavaris N
Pathol Oncol Res, 22(4):707-714, 31 Mar 2016
Cited by: 8 articles | PMID: 27033063
Add to export list
BcCluster: A Bladder Cancer Database at the Molecular Level.
Bhat A, Mokou M, Zoidakis J, Jankowski V, Vlahou A, Mischak H
Bladder Cancer, 2(1):65-76, 07 Jan 2016
Cited by: 3 articles | PMID: 27376128 | PMCID: PMC4927921
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Akt activation correlates with the tumor aggressiveness in Tunisian patients with bladder cancer.
Ben Bahria-Sediki I, Sampaio C, Chebil M, Cherif M, Zermani R, Rammeh S, Ben Ammar El Gaaied A, Bettaieb A
Tumour Biol, 37(6):7873-7879, 23 Dec 2015
Cited by: 1 article | PMID: 26700664
Add to export list
Alterations of mTOR and PTEN protein expression in schistosomal squamous cell carcinoma and urothelial carcinoma.
Makboul R, Refaiy A, Abdelkawi IF, Hameed DA, Elderwy AA, Shalaby MM, Merseburger AS, Hussein MR
Pathol Res Pract, 212(5):385-392, 09 Feb 2016
Cited by: 6 articles | PMID: 26916953
Add to export list
Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.
Costa C, Pereira S, Lima L, Lima L, Peixoto A, Fernandes E, Neves D, Neves M, Gaiteiro C, Tavares A, Gil da Costa RM, Cruz R, Amaro T, Oliveira PA, Ferreira JA, Santos LL
PLoS One, 10(11):e0141253, 16 Nov 2015
Cited by: 46 articles | PMID: 26569621 | PMCID: PMC4646664
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Comprehensive Molecular Analysis of NSCLC; Clinicopathological Associations.
Chatziandreou I, Tsioli P, Sakellariou S, Mourkioti I, Giannopoulou I, Levidou G, Korkolopoulou P, Patsouris E, Saetta AA
PLoS One, 10(7):e0133859, 24 Jul 2015
Cited by: 20 articles | PMID: 26208325 | PMCID: PMC4514742
Add to export list
This article is in the Europe PMC Open access subset. Refer to the copyright information in the article for licensing details.
Free full text in Europe PMC
Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma.
Tasioudi KE, Sakellariou S, Levidou G, Theodorou D, Michalopoulos NV, Patsouris E, Korkolopoulou P, Saetta AA
APMIS, 123(8):639-647, 27 Apr 2015
Cited by: 17 articles | PMID: 25912437
Add to export list
Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer.
Gargalionis AN, Korkolopoulou P, Farmaki E, Piperi C, Dalagiorgou G, Adamopoulos C, Levidou G, Saetta A, Fragkou P, Tsioli P, Kiaris H, Zizi-Serbetzoglou A, Karavokyros I, Papavassiliou KA, Tsavaris N, Patsouris E, Basdra EK, Papavassiliou AG
Int J Cancer, 136(7):1515-1527, 03 Sep 2014
Cited by: 31 articles | PMID: 25123959
Add to export list

1-25 of 42 results

1 2

Search life-sciences literature (45,104,206 articles, preprints and more)

Search results

Familial CCM Genes Might Not Be Main Drivers for Pathogenesis of Sporadic CCMs-Genetic Similarity between Cancers and Vascular Malformations.

2,5-Hexanedione Affects Ovarian Granulosa Cells in Swine by Regulating the CDKN1A Gene: A Transcriptome Analysis.

Identification of immuno-infiltrating MAP1A as a prognosis-related biomarker for bladder cancer and its ceRNA network construction.

NF2 Alteration/22q Loss Is Associated with Recurrence in WHO Grade 1 Sphenoid Wing Meningiomas.

Associations of Genetic Polymorphisms of mTOR rs2295080 T/G and rs1883965 G/A with Susceptibility of Urinary System Cancers.

Correlation of the AKT/mTOR signaling pathway with the clinicopathological features and prognosis of nasopharyngeal carcinoma.

Prognostic Role of the Activated p-AKT Molecule in Various Hematologic Malignancies and Solid Tumors: A Meta-Analysis.

Cytokine-Mediated Dysregulation of Signaling Pathways in the Pathogenesis of Multiple Myeloma.

The function and mechanism of circular RNAs in gastrointestinal tumours.

Mutations in gliclazide-associated genes may predict poor bladder cancer prognosis.

The Esophageal Cancer and the PI3K/AKT/mTOR Signaling Regulatory microRNAs: a Novel Marker for Prognosis, and a Possible Target for Immunotherapy.

Analysis of the PI3K-AKT-mTOR pathway in penile cancer: evaluation of a therapeutically targetable pathway.

Association between single nucleotide polymorphisms in the PI3K/AKT/mTOR pathway and bladder cancer risk in a sample of Iranian population.

Inhibition of PI3K/AKt/mTOR signaling pathway protects against d-galactosamine/lipopolysaccharide-induced acute liver failure by chaperone-mediated autophagy in rats.

Immunohistochemical Investigation of HER/AKT/mTOR Pathway and Cellular Adhesion Molecules in Urothelial Carcinomas.

AMPKα Is Suppressed in Bladder Cancer through Macrophage-Mediated Mechanisms.

Mutation of genes of the PI3K/AKT pathway in breast cancer supports their potential importance as biomarker for breast cancer aggressiveness.

The Prognostic Influence of BRAF Mutation and other Molecular, Clinical and Laboratory Parameters in Stage IV Colorectal Cancer.

BcCluster: A Bladder Cancer Database at the Molecular Level.

Akt activation correlates with the tumor aggressiveness in Tunisian patients with bladder cancer.

Alterations of mTOR and PTEN protein expression in schistosomal squamous cell carcinoma and urothelial carcinoma.

Abnormal Protein Glycosylation and Activated PI3K/Akt/mTOR Pathway: Role in Bladder Cancer Prognosis and Targeted Therapeutics.

Comprehensive Molecular Analysis of NSCLC; Clinicopathological Associations.

Immunohistochemical and molecular analysis of PI3K/AKT/mTOR pathway in esophageal carcinoma.

Polycystin-1 and polycystin-2 are involved in the acquisition of aggressive phenotypes in colorectal cancer.

Partnerships & funding